JPMorgan analysts urged investors to capitalize on the recent pullback in one medtech company's shares. The firm said in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE